Search research articles
Contact Us
Filters
Showing results (251-260 of 298) with videos related to
Page
of 30
Sort By:
Microbiology Spectrum
|
May 18, 2026
Effect of inhaled interferon-β1a on SARS-CoV-2 diversity and evolution
Gregory E Edelstein, Tatum N Sass, Rinki Deo, et al.
Open Forum Infectious Diseases
|
June 16, 2025
Prognostic Factors of Physical Function Decline Among Middle-Aged Adults With HIV
Grace L Kulik, Triin Umbleja, Todd T Brown, et al.
Open Forum Infectious Diseases
|
March 31, 2023
Coronary Artery Plaque Composition and Severity Relate to the Inflammasome in People With Treated Human Immunodeficiency Virus
Samuel R Schnittman, Douglas W Kitch, Talia H Swartz, et al.
Open Forum Infectious Diseases
|
October 22, 2024
Effects of Pitavastatin on COVID-19 Incidence and Seriousness Among a Global Cohort of People With HIV
Markella V Zanni, Triin Umbleja, Carl J Fichtenbaum, et al.
Pathogens & Immunity
|
May 20, 2026
Impact of Sex on Viral Shedding and Symptom Severity During Acute COVID-19
Evelyn Kung, Rinki Deo, Manish C Choudhary, et al.
JACC. Advances
|
August 21, 2025
Frailty, Pitavastatin, and Major Adverse Cardiovascular Events Among People With HIV
Kristine M Erlandson, Ariela R Orkaby, Triin Umbleja, et al.
The Journal of Infectious Diseases
|
July 10, 2020
Patterns of Antiretroviral Therapy Use and Immunologic Profiles at Enrollment in the REPRIEVE Trial
Carl J Fichtenbaum, Heather J Ribaudo, Jorge Leon-Cruz, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
June 27, 2025
Effect of Pitavastatin on Epigenetic Aging Biomarkers in People With HIV: Pilot Substudy of the REPRIEVE Trial
Michael J Corley, Maya Watanabe, Alina P S Pang, et al.
AIDS (London, England)
|
July 24, 2025
No evidence of pitavastatin effect on muscle area or density among people with HIV
Kristine M Erlandson, Triin Umbleja, Heather J Ribaudo, et al.
Nature Communications
|
August 22, 2022
Antiviral and clinical activity of bamlanivimab in a randomized trial of non-hospitalized adults with COVID-19
Kara W Chew, Carlee Moser, Eric S Daar, et al.
Page
of 30
Search research articles
Search
Showing results (251-260 of 298) with videos related to
Sort By:
Page
of 30
Microbiology Spectrum
|
May 18, 2026
Effect of inhaled interferon-β1a on SARS-CoV-2 diversity and evolution
Gregory E Edelstein, Tatum N Sass, Rinki Deo, et al.
Open Forum Infectious Diseases
|
June 16, 2025
Prognostic Factors of Physical Function Decline Among Middle-Aged Adults With HIV
Grace L Kulik, Triin Umbleja, Todd T Brown, et al.
Open Forum Infectious Diseases
|
March 31, 2023
Coronary Artery Plaque Composition and Severity Relate to the Inflammasome in People With Treated Human Immunodeficiency Virus
Samuel R Schnittman, Douglas W Kitch, Talia H Swartz, et al.
Open Forum Infectious Diseases
|
October 22, 2024
Effects of Pitavastatin on COVID-19 Incidence and Seriousness Among a Global Cohort of People With HIV
Markella V Zanni, Triin Umbleja, Carl J Fichtenbaum, et al.
Pathogens & Immunity
|
May 20, 2026
Impact of Sex on Viral Shedding and Symptom Severity During Acute COVID-19
Evelyn Kung, Rinki Deo, Manish C Choudhary, et al.
JACC. Advances
|
August 21, 2025
Frailty, Pitavastatin, and Major Adverse Cardiovascular Events Among People With HIV
Kristine M Erlandson, Ariela R Orkaby, Triin Umbleja, et al.
The Journal of Infectious Diseases
|
July 10, 2020
Patterns of Antiretroviral Therapy Use and Immunologic Profiles at Enrollment in the REPRIEVE Trial
Carl J Fichtenbaum, Heather J Ribaudo, Jorge Leon-Cruz, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
June 27, 2025
Effect of Pitavastatin on Epigenetic Aging Biomarkers in People With HIV: Pilot Substudy of the REPRIEVE Trial
Michael J Corley, Maya Watanabe, Alina P S Pang, et al.
AIDS (London, England)
|
July 24, 2025
No evidence of pitavastatin effect on muscle area or density among people with HIV
Kristine M Erlandson, Triin Umbleja, Heather J Ribaudo, et al.
Nature Communications
|
August 22, 2022
Antiviral and clinical activity of bamlanivimab in a randomized trial of non-hospitalized adults with COVID-19
Kara W Chew, Carlee Moser, Eric S Daar, et al.
Page
of 30